Skip to main content

Table 3 Observed and expected number of non-AIDS-defining cancers (NADCs) and all-cause deaths in patients with HIV compared with the general population in Japan

From: Increased risk of non-AIDS-defining cancers in Asian HIV-infected patients: a long-term cohort study

Cancer type Observed Expected SIR (95% CI)
Liver 9 1.9 4.7 (2.1–8.2)
Colorectal 15 7.7 1.9 (1.1–3.0)
Colon 10 4.7 2.1 (1.0–3.7)
Anorectal* 5 3.1 1.6 (0.5–3.4)
Gastric 11 6.0 1.8 (1.0–3.1)
Lung 8 4.4 1.8 (0.8–3.3)
Oral cavity and pharynx 3 1.0 2.9 (0.5–7.0)
Esophageal 2 1.4 1.4 (0.1–4.0)
Pancreas 1 1.2 0.8 (< 0.1–3.3)
Biliary tract 2 0.6 3.2 (0.3–9.2)
Bladder 2 0.8 2.4 (0.2–6.7)
Skin 1 0.6 1.8 (< 0.1–6.9)
Prostate 1 4.0 0.2 (< 0.1–1.0)
Thyroid 1 0.6 1.7 (< 0.1–6.5)
Breast 1 0.8 1.3 (< 0.1–5.0)
Hodgkin lymphoma 4 NAa NAa
  1. Note. *Anorectal cancer included rectal cancer (n = 2) and anal cancer (n = 3). aGeneral population data were not available for Hodgkin lymphoma
  2. Abbreviation Standardized incidence ratio, SIR standardized mortality ratio